Boston Scientific announced its plan to acquire the company for $10 per share in November.
Apollo’s main focus is on the design, development and commercialization of less invasive gastrointestinal and endoscopic devices.
This acquisition will mark Boston Scientific’s entry into the endobariatric market, according to an April 4 news release shared with Becker’s.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
